China National Medicines Corporation Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
3,024
- Stock Symbol
-
600511
- Investments
-
1
- Share Price
-
$4.27
- (As of Friday Closing)
China National Medicines Corporation General Information
Description
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
Contact Information
Website
www.cncm.com.cnCorporate Office
- Floors 6-9, West Tower, 7th Floor
- Number 8 Courtyard, Yongdingmen West Binhe Road, Dongcheng District
- Beijing, 100077
- China
Corporate Office
- Floors 6-9, West Tower, 7th Floor
- Number 8 Courtyard, Yongdingmen West Binhe Road, Dongcheng District
- Beijing, 100077
- China
China National Medicines Corporation Stock Performance
As of 20-Nov-2026, China National Medicines Corporation’s stock price is $4.27. Its current market cap is $3.23B with 755M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.27 | $4.33 | $3.69 - $4.48 | $3.23B | 755M | 4.66M | $0.38 |
China National Medicines Corporation Financials Summary
As of 30-Sep-2026, China National Medicines Corporation has a trailing 12-month revenue of $7.79B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,065,929 | 2,358,961 | 2,744,304 | 2,235,016 |
| Revenue | 7,789,905 | 7,296,057 | 7,051,457 | 7,024,295 |
| EBITDA | 371,281 | 390,671 | 393,149 | 423,447 |
| Net Income | 287,342 | 277,639 | 278,745 | 303,327 |
| Total Assets | 5,491,493 | 5,243,190 | 4,784,630 | 4,578,209 |
| Total Debt | 75,194 | 73,788 | 115,882 | 77,237 |
China National Medicines Corporation Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
China National Medicines Corporation Signals
China National Medicines Corporation Acquisitions (1)
China National Medicines Corporation’s most recent deal was a Merger/Acquisition with Sinopharm Holding Beijing Tianxingpuxin Bio-Med Company for . The deal was made on 01-Apr-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sinopharm Holding Beijing Tianxingpuxin Bio-Med Company | 01-Apr-2017 | Merger/Acquisition | Holding Companies |
China National Medicines Corporation ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
37.53 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Distribution
Subindustry
of 42
Rank
Percentile
China National Medicines Corporation FAQs
-
When was China National Medicines Corporation founded?
China National Medicines Corporation was founded in 1999.
-
Where is China National Medicines Corporation headquartered?
China National Medicines Corporation is headquartered in Beijing, China.
-
What is the size of China National Medicines Corporation?
China National Medicines Corporation has 3,024 total employees.
-
What industry is China National Medicines Corporation in?
China National Medicines Corporation’s primary industry is Pharmaceuticals.
-
Is China National Medicines Corporation a private or public company?
China National Medicines Corporation is a Public company.
-
What is China National Medicines Corporation’s stock symbol?
The ticker symbol for China National Medicines Corporation is 600511.
-
What is the current stock price of China National Medicines Corporation?
As of 20-Nov-2026 the stock price of China National Medicines Corporation is $4.27.
-
What is the current market cap of China National Medicines Corporation?
The current market capitalization of China National Medicines Corporation is $3.23B.
-
What is China National Medicines Corporation’s current revenue?
The trailing twelve month revenue for China National Medicines Corporation is $7.79B.
-
What is China National Medicines Corporation’s annual earnings per share (EPS)?
China National Medicines Corporation’s EPS for 12 months was $0.38.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process